Conference Coverage

Keto diet in MS tied to less disability, better quality of life


 

FROM AAN 2022

Remarkable adherence

Commenting on the study, Shaheen E. Lakhan, MD, PhD, a neurologist in Boston, noted that “variations of the ketogenic diet have been popularized in the general population for weight loss and further studied for other medical conditions [that are] largely immune-related, including MS.”

He noted that it was “remarkable” that the vast majority of study participants with MS adhered to the very regimented ketogenic diet for 6 months.

Seeing this translate into the real world “will be the next milestone, in addition to its impact on relapses and brain lesions as seen on MRI,” which are the classic markers of MS, said Dr. Lakhan, who was not involved with the research.

He cautioned that “even if one can follow the ketogenic diet, certain conditions can be made worse. This includes kidney stones, liver disease, reflux, constipation, and other metabolic disorders.”

The study was funded by the National Center for Advancing Translational Sciences of the National Institutes of Health and by the ZiMS Foundation. Dr. Brenton and Dr. Lakhan have reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

B-cell therapy for MS may impact COVID-19 vaccination
MDedge Neurology
Ozanimod shows long-term safety, despite a pandemic
MDedge Neurology
New guidelines on MRI use in patients with MS explained
MDedge Neurology
MRI biomarker to be tested in MS
MDedge Neurology
DMTs tied to lower MS relapse during reproductive therapy
MDedge Neurology
Home cognitive therapy looks feasible in MS
MDedge Neurology
B-cell depletion overkill?
MDedge Neurology
Early MS biomarkers may improve prediction of long-term outcomes
MDedge Neurology
Updates in DMTs and MS Economic Burden From ACTRIMS 2022
MDedge Neurology
ACTRIMS 2022: Updates in Multiple Sclerosis Symptom Management
MDedge Neurology